Dynavax Technologies Corp Files 8-K
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | 8-K |
| Filed Date | Aug 21, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Dynavax filed an 8-K on 8/21/25, likely containing important company updates.
AI Summary
On August 21, 2025, Dynavax Technologies Corporation filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates Dynavax Technologies Corporation is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific operational or financial details that would indicate a high risk.
Key Players & Entities
- Dynavax Technologies Corporation (company) — Registrant
- August 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Emeryville, California (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is August 21, 2025.
What is Dynavax Technologies Corporation's state of incorporation?
Dynavax Technologies Corporation is incorporated in Delaware.
Where are Dynavax Technologies Corporation's principal executive offices located?
The principal executive offices are located at 2100 Powell Street, Suite 720, Emeryville, California, 94608.
What is the Registrant's telephone number?
The Registrant's telephone number, including area code, is (510) 848-5100.
Filing Stats: 578 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2025-08-21 08:15:30
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value DVAX Nasdaq Global Select
Filing Documents
- d57006d8k.htm (8-K) — 26KB
- d57006dex991.htm (EX-99.1) — 32KB
- d57006dex992.htm (EX-99.2) — 36KB
- g57006dsp_aa.jpg (GRAPHIC) — 3KB
- g57006ex99_2s10g1.jpg (GRAPHIC) — 76KB
- g57006ex99_2s11g1.jpg (GRAPHIC) — 108KB
- g57006ex99_2s12g1.jpg (GRAPHIC) — 87KB
- g57006ex99_2s13g1.jpg (GRAPHIC) — 80KB
- g57006ex99_2s14g1.jpg (GRAPHIC) — 78KB
- g57006ex99_2s15g1.jpg (GRAPHIC) — 74KB
- g57006ex99_2s16g1.jpg (GRAPHIC) — 106KB
- g57006ex99_2s17g1.jpg (GRAPHIC) — 106KB
- g57006ex99_2s18g1.jpg (GRAPHIC) — 88KB
- g57006ex99_2s19g1.jpg (GRAPHIC) — 124KB
- g57006ex99_2s1g1.jpg (GRAPHIC) — 117KB
- g57006ex99_2s20g1.jpg (GRAPHIC) — 107KB
- g57006ex99_2s21g1.jpg (GRAPHIC) — 157KB
- g57006ex99_2s22g1.jpg (GRAPHIC) — 84KB
- g57006ex99_2s2g1.jpg (GRAPHIC) — 192KB
- g57006ex99_2s3g1.jpg (GRAPHIC) — 124KB
- g57006ex99_2s4g1.jpg (GRAPHIC) — 90KB
- g57006ex99_2s5g1.jpg (GRAPHIC) — 113KB
- g57006ex99_2s6g1.jpg (GRAPHIC) — 90KB
- g57006ex99_2s7g1.jpg (GRAPHIC) — 77KB
- g57006ex99_2s8g1.jpg (GRAPHIC) — 87KB
- g57006ex99_2s9g1.jpg (GRAPHIC) — 77KB
- 0001193125-25-184680.txt ( ) — 3321KB
- dvax-20250821.xsd (EX-101.SCH) — 3KB
- dvax-20250821_lab.xml (EX-101.LAB) — 18KB
- dvax-20250821_pre.xml (EX-101.PRE) — 11KB
- d57006d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated August 21, 2025 99.2 Corporate Presentation 104 Cover Page Interactive Data (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dynavax Technologies Corporation Date: August 21, 2025 By: /s/ RYAN SPENCER RYAN SPENCER Chief Executive Officer